Prostate cancer screening recommendations based on age and PSA levels, adapted from the National Comprehensive Cancer Network Clinical Practice Guidelines In Oncology (NCCN Guidelines®) for Prostate Cancer Early Detection.
Prostate Cancer Early Detection: Age Recommendations and PSA Levels Chart
Discuss risk and benefits of prostate cancer screening with your doctor
Age 40-75 • Black/African American individuals • Those with a family history of cancer and/or known genetic mutation that increases the risk for prostate cancer
Have a baseline PSA and strongly consider a baseline DRE
If PSA less than 1 ng/mL and DRE normal (if done), repeat testing every 2 – 4 years
If PSA 1 - 3 ng/mL and DRE normal (if done), repeat testing every 1 – 2 years
Age 45-75 • Average-risk individuals
If PSA greater than 3 ng/mL and/or a very suspicious DRE, talk with your doctor about further testing and follow-up Talk with your doctor about if prostate cancer screening should continue If PSA less than 4 ng/mL and DRE normal (if done), repeat testing in select patients every 1 – 4 years If PSA greater than 4 ng/mL or a very suspicious DRE, talk with your doctor about further testing and follow-up
Age 75+
Based on National Comprehensive Cancer Network ® Clinical Practice Guidelines in Oncology (NCCN Guidelines ® ) for Prostate Cancer Early Detection 2022
Page 1Made with FlippingBook flipbook maker